Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sales volume of Dupixent reaching USD 5.35 billion in H1 of the year, setting off a R&D boom of IL-4R in China

PharmaSources/YefenghongAugust 28, 2023

Tag: IL-4R , Dupixent , R&D

PharmaSources Customer Service